Burkitt Lymphoma - 25 Studies Found Completed : Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults : Burkitt's Lymphoma High-grade B-cell Lymphoma : 2013-03-08 : Other: No intervention (observational study) Completed : Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma : Lymphoma : 2006-10-25 : Biological: filgrastim given s Recruiting : Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM) : Lymphoma, Non-Hodgkin Malaria Herpesvirus 4, Human : 2010-09-04 Withdrawn : Study Evaluating the Efficacy of 90Yttrium-epratuzumab in Adults With CD22+ Relapsed/Refractory B-ALL : CD22+ Relapsed/Refractory B-ALL : 2015-11-13 : Drug: 90Y-epratuzumab tetraxetan Withdrawn : Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia : Relapsed or Refractory Acute Myeloid Leukemia Relapsed or Refractory B : 2014-08-07 : Drug: VS-4718 Completed : Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia : Leukemia Lymphoma : 2002-06-06 : Biological: filgrastim 5 ug/kg Not yet recruiting : Blinatumomab and Pembrolizumab for Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia With High Marrow Lymphoblasts : B-Cell Acute Lymphoblastic Leukemia, Adult : 2017-05-16 : Drug: blinatumomab Not yet recruiting : Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL) : Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia : 2010-04-12 : Biological: humanised monoclonal antibody, veltuzumab Completed : Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults : Burkitt's Lymphoma Burkitt's Leukemia : 2005-09-12 : Drug: Adriamycin Drug: Cyclophosphamide Completed : Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma : Burkitt's Lymphoma Burkitt'S-like Lymphoma : 2008-04-28 : Drug: Rituximab 375 mg/m2 IV d <<< Previous | Next >>>
